Uncategorised - European Medical Journal

Can the Gut Microbiome Influence Cancer Therapy Efficacy?

A novel review published has explored evidence surrounding the gut microbiome’s impact on patient responses to cancer therapies…

Impact of COVID-19 on Childhood and Adolescent Obesity

During Zoom Forward 2022, experts in obesity, endocrinology, and paediatrics discussed how the COVID-19 pandemic aggravated the obesity crisis…

Update on the Guidelines of Obesity Management

The Zoom Forward 22 Congress on 4th–7th May 2022 is a joint congress on obesity of the European Association of the Study of Obesity…

Review of Zoom Forward: The 29th European Congress on Obesity

SHARING insights on the theme of obesity, the 29th European Congress on Obesity was jointly hosted by the European Association for the Study of Obesity…

Biosimilars CME webinar

CME-Accredited Webinar on Biosimilars within Haematology & Oncology

This presidential debate-style discussion explores the topic of biosimilars within haematology and oncology.

CME webinar on biosimilar

CME-Accredited Webinar on Biosimilars within Rheumatology, Dermatology & Gastroenterology

This presidential debate-style discussion explores the topic of biosimilars within rheumatology, dermatology and gastroenterology.

REPRO

Female’s Experience with Post-placental Intrauterine Contraceptive Device Use in a Tertiary Care Centre in Pakistan

Analysing female experiences of contraception using a post-placental intra-uterine contraceptive device (IUD)…

Communication, data in R&D and leadership

In this episode, Helena and Marc are joined by Amgen’s Emma Booth to discuss all things R&D, plus medical affairs communication and more.

Janssen seeks to support LGBTQ+ community

A new campaign developed by and for the LGBTQ+ community has been launched by Janssen. Read for more details.

Sodium-Glucose Co-Transporter-2 Inhibitors in Heart Failure with Preserved Ejection Fraction

Heart Failure and Heart Failure with Preserved Ejection Fraction prognosis in relation to treatment with SGLT2 inhibitors…